| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immix Biopharma, Inc. (IMMX) has 9 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. IMMX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.14M | $11.98M | - | |
| CFO | 291.4K | $3.06M | - | |
| Dir | 39.6K | $415.9K | - | |
| 10% | 33.0K | $346.2K | - | |
| Dir | 33.0K | $346.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | Morris Gabriel S65 | Chief Financial Officer | Buy | 2,000 | $5.00 | $10,000.00 | +2.7% | -31.7% | -42.5% | |
| Dec 20, 2021 | Ng Carey | Director | Buy | 25,000 | $5.00 | $125,000.00 | +2.5% | -31.7% | -42.5% | |
| Dec 20, 2021 | Hsu Jason50 | Director | Buy | 50,000 | $5.00 | $250,000.00 | New | -31.7% | -42.5% |